Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemic
Clinical trial NCT06109831 · COMPLETED
Trial details
- NCT number
- NCT06109831
- Sponsor
- Beijing Suncadia Pharmaceuticals Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-24
- Primary completion
- 2025-07-04
- Enrollment
- 335
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.